Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer-Reference-Cited by-同舟云学术

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer

Published:2021-10-19 Issue:23 Volume:10 Page:8518-8529
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen Yu¹²,Liu Xinchao¹²,Huang Zhaoqin³,Zhao Kaikai⁴^ORCID,Wang Yao²,Ren Fei²,Yu Jinming¹²,Meng Xiangjiao¹²^ORCID

Affiliation:

1. Cheeloo College of Medicine Shandong University Jinan Shandong China

2. Department of Radiation Oncology Shandong Cancer Hospital and InstituteShandong First Medical University and Shandong Academy of Medical Sciences Jinan Shandong China

3. Department of Radiology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan Shandong China

4. Department of Radiation Oncology Yantai Affiliated Hospital of Binzhou Medical University Yantai Shandong China

Funder

Natural Science Foundation of Shandong Province

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4363

Reference38 articles.

1. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

2. Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

3. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

4. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

5. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancer;Radiation Oncology;2023-07-04

2. Case report: Pneumonia with clinical symptoms precedes imaging evidence after immune checkpoint inhibitors combined with radiotherapy in lung squamous cell cancer;Frontiers in Immunology;2022-09-15